Session 6, Presentation 4, Global Antibiotic Research and Development Partnership (GARDP)

Overview

The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation. 

Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.

WHO Team
One Health Global Leaders Group on Antimicrobial Resistance